Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Xalritel-40H Telmisartan and Hydrochlorothiazide Tablets:
Xalritel-40H is a combination medication containing Telmisartan and Hydrochlorothiazide, formulated as tablets. Each tablet typically contains Telmisartan 40 mg and Hydrochlorothiazide (HCTZ) 12.5 mg. It is prescribed for the treatment of hypertension (high blood pressure).
Uses of Xalritel-40H Telmisartan and Hydrochlorothiazide Tablets:
Xalritel-40H is used for:
Management of hypertension (high blood pressure) in patients requiring dual therapy.
Reduction of cardiovascular events associated with hypertension.
Benefits of Xalritel-40H Telmisartan and Hydrochlorothiazide Tablets:
Dual Action: Combines the antihypertensive effects of Telmisartan with the diuretic effects of Hydrochlorothiazide, achieving better blood pressure control.
Renal Protective Effects: Helps in preserving renal function in hypertensive patients.
Convenience: Provides a convenient once-daily dosing regimen.
Mechanism of Action of Xalritel-40H Telmisartan and Hydrochlorothiazide Tablets:
Telmisartan: Blocks the action of angiotensin II on AT1 receptors, leading to vasodilation and decreased secretion of aldosterone.
Hydrochlorothiazide: Increases the excretion of sodium and water by inhibiting sodium reabsorption in the distal convoluted tubule, resulting in diuresis and reduced blood volume.